BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18058470)

  • 1. Transforming growth factor-beta 1 gene polymorphisms and expression in the blood of prostate cancer patients.
    Faria PC; Saba K; Neves AF; Cordeiro ER; Marangoni K; Freitas DG; Goulart LR
    Cancer Invest; 2007 Dec; 25(8):726-32. PubMed ID: 18058470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
    Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
    Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
    Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
    Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N; Karyotis I; Delakas D; Spandidos DA
    Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression.
    Marangoni K; Araújo TG; Neves AF; Goulart LR
    BMC Cancer; 2008 Sep; 8():273. PubMed ID: 18823560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
    Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
    J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
    Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
    Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
    Alonso V; Neves AF; Marangoni K; Faria PC; Freschi AP; Capaneli AC; Meola J; Goulart LR
    Cancer Detect Prev; 2009; 32(4):336-7. PubMed ID: 19026495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
    Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative detection of differential display code 3 mRNA in peripheral blood of patients with prostate cancer].
    Weng ZL; Yu KY; Mao XL; Tao ZH; Chen XD; Wu XL; Hu YP; Wang SQ; Li CD; Chen ZG
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2911-5. PubMed ID: 17288789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
    Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
    Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
    Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
    Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DD3(PCA3) gene expression in cancer and prostatic hyperplasia.
    Floriano-Sánchez E; Cárdenas-Rodríguez N; Castro-Marín M; Alvarez-Grave P; Lara-Padilla E
    Clin Invest Med; 2009 Dec; 32(6):E258. PubMed ID: 20003831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
    Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility.
    Teixeira AL; Ribeiro R; Morais A; Lobo F; Fraga A; Pina F; Calais-da-Silva FM; Calais-da-Silva FE; Medeiros R
    Pharmacogenomics J; 2009 Oct; 9(5):341-6. PubMed ID: 19488063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.